Depression symptoms of African American patients with cancer under-recognized
the ONA take:
Depression symptoms of African American patients with cancer are often under-recognized, a new study by researchers at Case Western Reserve University in Cleveland, Ohio, has found.
For the study, researchers sought to investigate whether depression in African American patients with cancer goes under-recognized for treatment.
The researchers identified 34 depressed African American cancer patients, 23 non-depressed African American cancer patients, and 17 depressed Caucasian cancer patients at a Northeast Ohio medical center.
All participants had been diagnosed with early-stage breast or prostate cancer within the last 3 years and received their last treatment at least 6 months ago. Patients were asked open-ended questions to assess their depression.
Results showed that depressed African American patients reported more irritability, wanting to be alone, insomnia, fatigue, and crying than non-depressed black patients.
Researchers also found that depressed black patients reported sad feelings less frequently than depressed white patients. Black patients were also more likely to use words like "feeling down," "low," "gloomy," or "blue" to describe their feeling rather than "depressed."
Depression symptoms of African American patients with cancer are often under-recognized.
- More Than Half of Melanomas Are Self-Detected, Especially by Women
- Childhood Cancer Linked to Poor Diet Quality in Adult Survivors
- New Research Identifies Potential Bladder Cancer Chemotherapy Side Effect
- Olaratumab in Combo With Doxorubicin Approved for Soft Tissue Sarcoma
- Hydroxyurea May Improve Kidney Function in PV-Associated Nephrotic Syndrome
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Study Identifies Factors Associated With Infection-related Complications in ALL
- Immune Checkpoint-Related Neurotoxicity May Be More Common During Combination Treatment
- New Recommendations for Secondary Prevention of Cervical Cancer
- Nonadherence to Posttreatment Imaging Follow-up Common Among Breast Cancer Survivors
- HIIT Improves Cardiorespiratory Fitness in Patients With Resectable NSCLC
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|